Fig. 5.

Overview of triptan use patterns and analysis of triptan discontinuation by patients with migraine without triptan contraindications in the entire German SHI population. a Flow chart depicting the use of triptans by German patients with migraine and identification of an extrapolated 576,122 patients who received a migraine diagnosis after discontinuing use of triptans (termed ‘triptan discontinuers’). b Extrapolated numbers and sex distribution of the triptan discontinuer population. c Extrapolated prevalence of triptan discontinuation within the total triptan experienced patient population categorized by age and sex